Skip to content
Screener

Organogenesis Holdings Inc. ORGO Q2 2025 earnings

Reported August 7, 2025 · After market close

Revenue$101.0MMiss by $33.1M
EPS-$0.09Miss by $0.16
Revenue estimate$134.1M
EPS estimate$0.07

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$52.1M
EPS estimate-$0.18

Financials

Q2 2025

Income statement

See full
Revenue$101.0M-22.4%
Operating income-$12.6M+9.5%
Net income-$9.4M+44.9%
EPS (diluted)-$0.10+23.1%

Balance sheet

See full
Cash & equivalents$73.1M-18.7%
Total debt$30.7M-71.3%
Total equity$233.2M-11.5%
Total assets$461.1M+4.1%

Cash flow

See full
Operating cash flow-$32.9M-794%
CapEx$3.6M+93.5%
Free cash flow-$36.5M—

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$438.91M+18.9%
Enterprise value$396.51M+2.7%
P/S1×+0.2×

Profitability

See full
Net margin-1.9%—

Returns & leverage

See full
Return on equity-3.3%—
Debt / equity0.1×-0.3×
Current ratio4×+1.2×

Segments

By product

See full
Grant$226.0K—

FAQ

When did Organogenesis Holdings Inc. report Q2 2025 earnings?
Organogenesis Holdings Inc. (ORGO) reported Q2 2025 earnings on August 7, 2025 after market close.
What were Organogenesis Holdings Inc.'s Q2 2025 revenue and EPS?
Organogenesis Holdings Inc. reported revenue of $101.0M and eps of $-0.09 for Q2 2025.
Did Organogenesis Holdings Inc. beat estimates in Q2 2025?
Revenue missed the consensus estimate of $134.1M by $33.1M. EPS missed the consensus estimate of $0.07 by $0.16.
How did Organogenesis Holdings Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 22.4% from $130.2M a year earlier and eps grew 30.8% from $-0.13.
Where can I find Organogenesis Holdings Inc.'s Q2 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-105032) and the 10-Q periodic report (0000950170-25-105048) directly on SEC EDGAR. The filing index links above go to sec.gov.